News

News Read More

December 8, 2025

Gannet BioChem Achieves Science Based Targets initiative (SBTi) Validation for Near-Term Climate Commitments

• Portfolio Company News

News Read More

November 19, 2025

P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence

• Portfolio Company News

News Read More

October 30, 2025

Vantage MedTech Appoints Carlo W. Colesanti as President and Chief Executive Officer; Jim Bartel to Serve as Chief Commercial Officer; Randy Barko Named Executive Chairman of the Board

• Portfolio Company News

News Read More

October 30, 2025

Ampersand Capital Partners Named to Inc.’s 2025 List of Founder-Friendly Investors for Fourth Consecutive Year

• Ampersand News

News Read More

October 14, 2025

Life Sciences Innovator Dr. Art Tipton Joins Gannet BioChem Board; Company to Attend PODD 2025

• Portfolio Company News

News Read More

September 23, 2025

Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer

• Portfolio Company News

News Read More

September 3, 2025

Ampersand Capital Partners Expands Global Presence with London Office, Appoints Matthew Norton as General Partner

• Ampersand News

News Read More

August 21, 2025

Ampersand Capital Partners Named a Top Private Equity Firm of 2025 by GrowthCap

• Ampersand News